Home › Funds › UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME › AMGN

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME position in AMGN

AMGEN INC · Health Care

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME reported holding 5,390,910 shares of AMGN (AMGEN INC) in its Q2 2026 13F filing — a position valued at US$1.95B, representing 0.36% of its reported portfolio and ranking #45 among its reported holdings. UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME has disclosed AMGN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)5.39M sh
Reported value held$1.95B
Portfolio Weight0.36%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME's AMGN position evolved

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME first disclosed a stake in AMGN in Q3 2023 at 3,305,650 shares (US$888.4M). The position peaked in Q2 2026 at 5,390,910 shares, worth US$1.95B. Across 12 filings, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 5,390,910 shares valued at US$1.95B — an increase of 605,928 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.31M $888.43M New
Q4 2023 3.62M $1.04B Add
Q1 2024 3.37M $957.17M Reduce
Q2 2024 4.18M $1.31B Add
Q3 2024 4.44M $1.43B Add
Q4 2024 5.13M $1.34B Add
Q1 2025 4.65M $1.45B Reduce
Q2 2025 5.28M $1.47B Add
Q3 2025 4.55M $1.28B Reduce
Q4 2025 4.60M $1.51B Add
Q1 2026 4.78M $1.68B Add
Q2 2026 5.39M $1.95B Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AMGN and 13F data

AMGN (AMGEN INC) is a Health Care company. 31 other funds we track also report a position in AMGN — the largest reported positions include BlackRock Inc (US$17.87B), STATE STREET CORP (US$10.75B), Capital World Investors (US$10.53B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AMGN

All AMGN fund holders →

FAQ

How long has UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME held AMGN?

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME has disclosed AMGN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME's current position in AMGN?

As of Q2 2026, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME holds 5.39M shares of AMGN (AMGEN INC), valued at $1.95B, representing 0.36% of its reported portfolio and ranking #45.

Has UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME been buying or selling AMGN?

In the latest 13F filing (Q2 2026), UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME increased its position in AMGN. The position peaked in Q2 2026 at 5.39M shares.

Which other funds hold AMGN?

Other major institutional holders of AMGN include BlackRock Inc, STATE STREET CORP, Capital World Investors, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.